Anti-HBc of IgM-class, HBeAg and anti-HBe in acute and chronic hepatitis B. 1981

J Aldershvile, and M Roggendorf, and P Kryger, and U Tage-Jensen, and F Deinhardt, and G G Frösner, and F Hardt, and J O Nielsen

The presence and persistence of IgM antibody against hepatitis B core antigen (anti-HBc IgM) and the correlation with other HBV markers were studied in 42 patients, all of whom had acute HBsAg-positive hepatitis but whose subsequent diseases differed. All patients initially had anti-HBc IgM. In 13 out of 15 patients with uncomplicated acute hepatitis, anti-HBc IgM disappeared within 6 months after onset of the disease. In five out of 12 patients, who in spite of transient HBsAg developed chronic liver disease, the anti-HBc IgM persisted for more than 2 years. Among 15 patients with persistent HBsAg, anti-HBc IgM was present from 7 months to more than 8 years. Seroconversion from HBeAg to anti-HBe was observed in seven patients and in five of these anti-HBc IgM disappeared during the follow-up period. These results indicate that anti-HBc IgM can be used as a serological marker of recent or ongoing HBV infection.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006511 Hepatitis B Antigens Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS. HBAg,Hepatitis B Antigen,Antigen, Hepatitis B,Antigens, Hepatitis B,B Antigen, Hepatitis,B Antigens, Hepatitis
D006512 Hepatitis B Core Antigens The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion. HBcAg,Hepatitis B Core Antigen
D006513 Hepatitis B e Antigens A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G. HBeAg,Hepatitis B e Antigen,Hepatitis Be Antigen,e Antigen,e Antigens,HBe Ag-1,HBe Ag-2,Hepatitis Be Antigens,Antigen, Hepatitis Be,Antigen, e,Antigens, Hepatitis Be,Antigens, e,Be Antigen, Hepatitis,Be Antigens, Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Aldershvile, and M Roggendorf, and P Kryger, and U Tage-Jensen, and F Deinhardt, and G G Frösner, and F Hardt, and J O Nielsen
December 1980, Journal of virological methods,
J Aldershvile, and M Roggendorf, and P Kryger, and U Tage-Jensen, and F Deinhardt, and G G Frösner, and F Hardt, and J O Nielsen
January 1987, Hepatology (Baltimore, Md.),
J Aldershvile, and M Roggendorf, and P Kryger, and U Tage-Jensen, and F Deinhardt, and G G Frösner, and F Hardt, and J O Nielsen
January 1981, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale,
J Aldershvile, and M Roggendorf, and P Kryger, and U Tage-Jensen, and F Deinhardt, and G G Frösner, and F Hardt, and J O Nielsen
January 1981, Die Medizinische Welt,
J Aldershvile, and M Roggendorf, and P Kryger, and U Tage-Jensen, and F Deinhardt, and G G Frösner, and F Hardt, and J O Nielsen
September 1984, Klinische Wochenschrift,
J Aldershvile, and M Roggendorf, and P Kryger, and U Tage-Jensen, and F Deinhardt, and G G Frösner, and F Hardt, and J O Nielsen
May 1985, Lijecnicki vjesnik,
J Aldershvile, and M Roggendorf, and P Kryger, and U Tage-Jensen, and F Deinhardt, and G G Frösner, and F Hardt, and J O Nielsen
April 1981, Gastroenterology,
J Aldershvile, and M Roggendorf, and P Kryger, and U Tage-Jensen, and F Deinhardt, and G G Frösner, and F Hardt, and J O Nielsen
November 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
J Aldershvile, and M Roggendorf, and P Kryger, and U Tage-Jensen, and F Deinhardt, and G G Frösner, and F Hardt, and J O Nielsen
April 2015, World journal of gastroenterology,
J Aldershvile, and M Roggendorf, and P Kryger, and U Tage-Jensen, and F Deinhardt, and G G Frösner, and F Hardt, and J O Nielsen
October 1986, Casopis lekaru ceskych,
Copied contents to your clipboard!